Kienböck's Disease (Adult)

1. Clinical Overview

Summary

Kienböck's disease is avascular necrosis (AVN) of the lunate bone, one of the eight carpal bones in the wrist. [1,2] First described by Austrian radiologist Robert Kienböck in 1910, it represents a progressive, debilitating condition characterised by lunate ischaemia, necrosis, fragmentation, and eventual collapse with secondary radiocarpal arthritis. [1,21]

The disease predominantly affects young to middle-aged adults (20-45 years), with a male preponderance (M:F ratio 2-3:1), and shows a strong association with manual labour and repetitive mechanical stress. [1,2] The pathophysiology remains incompletely understood but involves both vascular insufficiency (anatomical variations in lunate blood supply) and biomechanical factors, particularly negative ulnar variance, which increases load transmission through the lunate. [4,5]

Clinical presentation is typically insidious dorsal wrist pain, progressive stiffness, and grip weakness. [1,2] Diagnosis relies on plain radiographs for staging and MRI for early detection (Stage I disease may be radiographically occult). [14,16] The Lichtman classification (Stages I-IV) guides treatment, which ranges from conservative immobilisation and activity modification in early disease to joint-levelling procedures (radial shortening osteotomy, ulnar lengthening), revascularisation (vascularised bone grafts), salvage arthroplasty (proximal row carpectomy), or wrist fusion in advanced arthritis. [1,7,8,16]

Prognosis depends on stage at presentation: early intervention (Stages I-IIIA) can halt progression and preserve wrist function, whereas advanced disease (Stages IIIB-IV) often requires salvage procedures with limited functional recovery. [9,10,11,24]

---

Key Facts

---

Clinical Pearls

"Negative Ulnar Variance is Key": Up to 78% of Kienböck's patients have negative ulnar variance (ulna shorter than radius), which increases lunate load by up to 45%. [4,5] Joint-levelling procedures (radial shortening or ulnar lengthening) aim to redistribute forces across the carpus.

"MRI Before Radiographs Normalise": Stage I disease shows normal plain radiographs but low signal on T1-weighted MRI (indicating marrow oedema/ischaemia). [14] Early MRI diagnosis is critical for successful joint-preserving surgery.

"The Lunate is the 'Keystone' of the Carpus": Lunate collapse leads to proximal migration of the capitate, fixed scaphoid flexion (DISI deformity), and loss of carpal height (carpal height ratio less than 0.50 indicates advanced disease). [1,16]

"Stage IIIB is the 'Point of No Return'": Once carpal height is lost and fixed scaphoid rotation occurs (Stage IIIB), joint-levelling procedures fail; salvage surgery (PRC, fusion) becomes necessary. [7,8,16]

"Vascularised Bone Grafts Show Promise": Meta-analysis demonstrates vascularised bone grafts (from distal radius, 4th/5th ECA pedicles) improve pain and function in Stages II-IIIA, with 76% radiological improvement. [23,24]

"Beware the 'Signal-Compromised Lunate' Mimics": MRI low signal in lunate also occurs in scapholunate advanced collapse (SLAC wrist), ulnar impaction syndrome, and TFCC tears—correlate with clinical context and radiographs. [14]

---

2. Epidemiology

Incidence and Prevalence

Kienböck's disease is a rare condition with an estimated incidence of 1-7 cases per 100,000 population per year. [1,2] True prevalence is unknown due to underdiagnosis of early-stage disease (many asymptomatic Stage I cases may resolve spontaneously or remain undetected). [1]

Geographic variation exists, with higher reported rates in Scandinavia and East Asia, potentially reflecting genetic predisposition, occupational exposure, or referral bias. [1,5]

---

Demographics

Occupational Risk: Exposure to repetitive vibration (pneumatic tools, jackhammers) and high-impact loading (hammering, heavy lifting) increases risk 2-4 fold. [1,2]

---

Risk Factors

Exam Detail: #### Anatomical Risk Factors

1. Negative Ulnar Variance [4,5]

   • Present in 60-80% of Kienböck's patients (vs. 23% general population)
   • Each 1 mm of negative ulnar variance increases lunate load by ~9-10%
   • Mechanism: Shortening of ulna shifts load from TFCC to lunate fossa of radius
   • Ulnar variance measurement: PA radiograph with shoulder 90° abducted, elbow 90° flexed, neutral forearm rotation; perpendicular lines drawn at distal radial articular surface and ulnar dome

2. Lunate Vascular Anatomy [1,21]

   • Lunate supplied by palmar and dorsal interosseous arteries from radial/ulnar systems
   • 15-20% of individuals have single-vessel supply (intraosseous Y-pattern absent)
   • Single-vessel lunates at higher risk of global ischaemia if vessel injury/thrombosis occurs
   • Type I lunate (no medial facet for hamate articulation) may be more vulnerable [1]

3. Lunate Morphology [1]

   • Viegas Type I lunate (no hamate facet): 65% of population, associated with Kienböck's
   • Viegas Type II lunate (medial facet for hamate): 35% of population, protective (load shared with hamate)

4. Carpal Morphology [1]

   • Short radial inclination and reduced radial height may alter load distribution
   • Small lunate fossa of distal radius increases contact stress

Biomechanical Risk Factors

5. Repetitive Axial Loading [1,2]

   • Occupations involving high-impact wrist loading (hammering, punching)
   • Vibration exposure from power tools (pneumatic drills, grinders)

6. Trauma [1]

   • Acute distal radius fracture (malunion with altered mechanics)
   • Chronic repetitive microtrauma (gymnasts, manual labourers)

Systemic/Medical Risk Factors

7. Systemic Lupus Erythematosus (SLE) [1,2]
   • Association with vasculitis and microthrombi
8. Sickle Cell Disease [1]
   • Vaso-occlusive crises causing intraosseous thrombosis
9. Corticosteroid Use [1]
   • Chronic steroid therapy (AVN risk factor for multiple sites)
10. Coagulation Disorders [1]

• Thrombophilia, hypofibrinolysis (rare associations)

---

3. Aetiology and Pathophysiology

Aetiological Theories

The exact aetiology of Kienböck's disease remains multifactorial and incompletely understood. [1,2,21] Three main theories have been proposed:

1. Vascular Theory (Primary Insufficiency)

• Lunate blood supply is tenuous and variable. [21]
• 15-20% of individuals have single-vessel supply (absent Y-anastomosis between palmar and dorsal vessels).
• Thrombosis, injury, or compression of sole nutrient vessel → global ischaemia → osteonecrosis.
• Supported by MRI findings of early marrow oedema and avascular zones on gadolinium-enhanced sequences. [14]

2. Biomechanical Theory (Secondary Insufficiency)

• Negative ulnar variance increases lunate loading by up to 45% (load normally shared 82% radius, 18% ulna shifts to ~95% radius when ulna is shortened). [4,5]
• Chronic repetitive compression stress causes microfractures, intraosseous hypertension, and vascular compromise (similar to Legg-Calvé-Perthes in hip).
• Lunate as the "keystone" of proximal carpal row bears maximal load during wrist extension and gripping. [1]

3. Combined Vascular-Biomechanical Theory (Current Consensus)

• Predisposing vascular anatomy (single-vessel supply) + biomechanical overload (negative ulnar variance, repetitive trauma) → ischaemia → necrosis → collapse. [1,2]
• Explains why not all individuals with negative ulnar variance develop Kienböck's (vascular anatomy varies).

---

Molecular Pathophysiology

Exam Detail: #### Stage 1: Ischaemia (Lichtman Stage I)

1. Vascular Insufficiency

   • Reduced intraosseous blood flow (measured by MRI perfusion/bone scintigraphy)
   • Hypoxia → anaerobic metabolism → lactic acid accumulation → pH drop

2. Bone Marrow Oedema

   • Interstitial fluid accumulation → increased intraosseous pressure → further vascular compression (vicious cycle)
   • MRI: Low T1 signal, high T2/STIR signal (oedema pattern) [14]

3. Osteocyte Death

   • Hypoxia-induced apoptosis
   • Loss of viable osteocytes → "ghost bones" on histology (empty lacunae, no nuclei)

Stage 2: Necrosis and Repair Attempts (Lichtman Stage II)

4. Necrotic Bone Resorption

   • Granulation tissue invasion from peripheral viable bone
   • Osteoclastic resorption of necrotic trabeculae

5. Attempted Revascularisation

   • Angiogenesis from surrounding capsular/periosteal vessels
   • Creeping substitution: new bone deposited on necrotic scaffolds

6. Sclerosis

   • Radiographic sclerosis reflects calcified dead bone + attempted new bone formation (not increased density, but slow resorption)
   • Mechanical strength remains compromised despite sclerotic appearance [1,16]

Stage 3: Fragmentation and Collapse (Lichtman Stage IIIA-IIIB)

7. Structural Failure

   • Weakened lunate unable to withstand compressive loads
   • Microfractures → gross fragmentation → collapse (height loss)

8. Carpal Malalignment

   • Lunate collapse → proximal migration of capitate → dorsal intercalated segment instability (DISI) (scaphoid assumes flexed posture)
   • Loss of carpal height ratio (normal: 0.54 ± 0.03; Kienböck's: less than 0.50 in Stage IIIB) [1,16]

9. Cartilage Degeneration

   • Altered contact mechanics → increased radioscaphoid and radiolunate contact stress
   • Chondrocyte apoptosis, proteoglycan degradation

Stage 4: Osteoarthritis (Lichtman Stage IV)

10. Pancarpal Arthritis
    • Radioscaphoid arthritis (most common)
    • Radiolunate arthritis
    • Capitolunate degeneration
    • Scapholunate advanced collapse (SLAC) pattern may supervene [1,2]

---

Biomechanics of the Lunate

---

4. Clinical Presentation

Symptoms

Kienböck's disease presents with insidious, progressive symptoms over months to years. [1,2] Acute presentation is rare (may follow trauma that unmasks pre-existing disease).

Pain Pattern:

• Activity-related: Worse at end of work day (manual labourers)
• Night pain: Uncommon (unlike inflammatory arthritis)
• Rest pain: Suggests advanced arthritis (Stage IV)

---

Typical Patient Profile

Clinical Pearl: "Classic Kienböck's Patient"

• 32-year-old male carpenter (10 years using vibrating power tools)
• 6-month history of progressive dominant (right) wrist pain
• Pain dorsal, central, deep, worse with hammering and lifting
• Reduced grip strength (drops tools frequently)
• No history of acute trauma
• Examination: Tenderness over dorsal lunate, reduced extension (40° vs. 70° on left), weak grip
• X-ray: Lunate sclerosis with early fragmentation (Lichtman Stage II-IIIA)
• MRI: Low T1 signal throughout lunate, no carpal height loss yet
• Ulnar variance: -3 mm (negative)

---

Red Flag Symptoms

---

5. Clinical Examination

Systematic Examination of the Wrist

Inspection

Palpation

Palpation Pearl: "Lunate is proximal to capitate": Locate capitate by tracing 3rd metacarpal base proximally; lunate is immediately proximal (feels like a small "bump" dorsally). Tenderness here is 85-90% sensitive for Kienböck's. [1]

Range of Motion (ROM)

Measure active and passive ROM; compare to contralateral wrist.

ROM Pattern: "Extension loss > flexion loss" is characteristic (capitate drops into lunate defect during extension).

Strength Testing

Special Tests

Exam Detail: ##### 1. Axial Compression Test

• Technique: Hold patient's hand; apply axial load through 3rd metacarpal (compress capitate into lunate)
• Positive: Sharp dorsal wrist pain (lunate compression)
• Sensitivity: ~75%; Specificity: ~60% (also positive in radiocarpal arthritis)

2. Ballottement Test (Reagan Test)

• Technique: Stabilise lunate dorsally with one thumb; ballotte capitate palmarly/dorsally with other thumb
• Positive: Pain, crepitus, excessive laxity (suggests lunocapitate instability)
• Indicates: Advanced disease (Stage IIIB-IV)

3. Watson Scaphoid Shift Test

• Technique: Apply pressure on scaphoid tuberosity (palmar); deviate wrist radially to ulnarly
• Positive: "Clunk" as scaphoid subluxes dorsally (scapholunate ligament insufficiency)
• Significance: May be positive in Kienböck's Stage IIIB-IV due to secondary scapholunate dissociation (lunate collapse → altered carpal mechanics)

4. Piano Key Test (DRUJ Instability)

• Technique: Press down on ulnar head; assess spring-back
• Positive: Excessive dorsal mobility
• Significance: Rules out ulnar impaction syndrome (differential diagnosis)

5. Ulnocarpal Stress Test

• Technique: Ulnar deviation + axial loading + pronation/supination
• Positive: Ulnar-sided pain
• Significance: Negative test helps differentiate from TFCC/ulnocarpal pathology

---

Differential Diagnosis on Examination

---

6. Investigations

Imaging Modalities

Plain Radiographs

Gold standard for staging and monitoring progression. [1,2,16]

Views Required

1. Posteroanterior (PA): Shoulder 90° abducted, elbow 90° flexed, forearm neutral
2. Lateral: True lateral (ensure radius and ulna superimposed)
3. Clenched-fist PA (dynamic): May reveal early collapse/carpal height loss

Radiographic Findings by Lichtman Stage

Carpal Height Ratio = (Carpal height / 3rd metacarpal length)

• Normal: 0.54 ± 0.03
• Stage IIIB/IV: less than 0.50 (indicates fixed carpal collapse) [1,16]

Ulnar Variance Measurement [4,5]

• Technique: PA radiograph (shoulder 90°, elbow 90°, neutral forearm); draw perpendicular lines at distal radial articular surface and ulnar dome
• Measurement: Distance between lines (negative = ulna shorter; positive = ulna longer; neutral = equal length)
• Interpretation:
  • "Normal population: Mean +0.9 mm (range -4 to +6 mm); ~23% have negative variance"
  • "Kienböck's patients: Mean -2.5 mm (range -6 to 0 mm); 60-80% have negative variance [4,5]"

Clinical Pearl: "Each 1 mm of negative ulnar variance increases lunate load by ~9%"; -3 mm variance → 27% increased load. [4,5]

---

Magnetic Resonance Imaging (MRI)

Most sensitive modality for early diagnosis (detects Stage I disease before radiographic changes). [14]

MRI Sequences and Findings

MRI Staging Correlation: [14]

• Stage I: Normal radiographs + low T1, high T2 signal (oedema pattern)
• Stage II: Sclerotic radiographs + low T1, low T2 signal (sclerosis pattern)
• Stage III-IV: Collapse on radiographs + heterogeneous signal, fragmentation, secondary changes (DISI, arthritis)

Gadolinium Enhancement Patterns

• Non-enhancement (avascular zones): Confirms necrosis [14]
• Rim enhancement: Peripheral viable bone attempting revascularisation
• Diffuse enhancement: Inflammatory synovitis (secondary)

Clinical Use: MRI indicated when:

1. Clinical suspicion but normal radiographs (rule in/out Stage I)
2. Pre-operative planning for vascularised bone graft (assess lunate vascularity)
3. Monitoring revascularisation post-surgery (repeat MRI at 6-12 months)

---

Computed Tomography (CT)

Role: Assessment of fragmentation geometry and pre-operative planning for salvage procedures. [16]

CT Findings and Applications

When to Order CT:

• Pre-operative planning for proximal row carpectomy (assess capitolunate/radial head cartilage)
• Complex fragmentation (> 3 fragments) to assess reconstructability
• Post-operative assessment of osteotomy healing (radial shortening)

---

Bone Scintigraphy (Technetium-99m)

Historical modality; largely replaced by MRI. [1]

• Findings: Increased uptake in lunate (all stages except late Stage I with photopenia)
• Limited role: Non-specific (increased uptake in any arthritis, fracture); poor spatial resolution
• Current use: Rarely used; may help if MRI contraindicated (pacemaker, claustrophobia)

---

Wrist Arthroscopy

Role: Diagnostic (when imaging equivocal) and prognostic (assess cartilage viability). [1,2]

Arthroscopic Staging (Bain & Begg Classification)

Indications for Arthroscopy:

1. Diagnostic uncertainty: Imaging suggests early disease but symptoms disproportionate (assess chondral integrity)
2. Pre-operative assessment before bone graft (confirm cartilage intact)
3. Therapeutic: Debridement, synovectomy (limited role)

---

Laboratory Investigations

Kienböck's disease is not diagnosed by blood tests, but investigations may identify systemic causes or rule out differentials. [1,2]

---

Lichtman Classification (Staging System)

Gold standard staging system for Kienböck's disease, guiding treatment decisions. [7,8]

Exam Detail: #### Original Lichtman Classification (1982) [7]

Modified Lichtman Classification (1993) [8]

Added Stage IIIC: Lunate collapse with coronal plane fracture (lunate splits into volar and dorsal fragments on lateral radiograph). Prognosis poor; requires salvage surgery.

Reliability and Validity

• Inter-observer reliability: Moderate (κ = 0.52-0.67) [7]
• Intra-observer reliability: Good (κ = 0.70-0.82) [7]
• Challenges: Distinguishing IIIA from IIIB (subjective assessment of scaphoid rotation and carpal height); MRI and clenched-fist radiographs improve accuracy [8,16]

---

7. Management

Treatment of Kienböck's disease is stage-dependent and aims to:

1. Relieve pain
2. Preserve/restore wrist function
3. Halt disease progression
4. Prevent osteoarthritis

No treatment can "reverse" established necrosis, but early intervention (Stages I-IIIA) can unload the lunate, promote revascularisation, and prevent collapse. [1,2,9,10,24]

---

Non-Operative Management

Indications

1. Stage I disease (asymptomatic or minimal symptoms)
2. Low-demand patients (elderly, sedentary)
3. Patient preference (refuse surgery)
4. Medical comorbidities precluding surgery

Treatment Modalities

Outcomes: Non-operative treatment rarely halts progression in symptomatic patients; 50-70% require surgery within 2 years. [1,2] Reserved for Stage I with minimal symptoms or palliative care in non-surgical candidates.

---

Operative Management

Surgery is the mainstay for symptomatic Kienböck's disease (Stages II-IV). [1,2,9,10,11,23,24]

Algorithm: Treatment by Lichtman Stage

┌────────────────────────────────────────────────────────────────────┐
│                 KIENBÖCK'S DISEASE SURGICAL ALGORITHM              │
├────────────────────────────────────────────────────────────────────┤
│                                                                    │
│  STAGE I (Normal X-ray, MRI changes only)                          │
│  ├─ Asymptomatic or minimal pain:                                 │
│  │  └─ Observation + activity modification                        │
│  ├─ Symptomatic despite immobilisation:                           │
│  │  └─ Consider radial shortening osteotomy (if -ve ulnar var)    │
│  │     OR vascularised bone graft (if neutral/+ve ulnar var)      │
│                                                                    │
│  STAGE II (Sclerosis, no collapse)                                 │
│  ├─ Negative ulnar variance:                                      │
│  │  └─ RADIAL SHORTENING OSTEOTOMY (gold standard) [9,10,11]      │
│  │     OR ulnar lengthening osteotomy (alternative)               │
│  ├─ Neutral or positive ulnar variance:                           │
│  │  └─ VASCULARISED BONE GRAFT (distal radius, 4th/5th ECA) [23]  │
│  ├─ Advanced IIIA (early fragmentation, no height loss):          │
│  │  └─ Radial shortening OR vascularised bone graft               │
│                                                                    │
│  STAGE IIIA (Collapse, carpal height preserved)                    │
│  ├─ Early IIIA (minimal fragmentation):                           │
│  │  └─ Radial shortening OR capitate shortening + bone graft      │
│  ├─ Late IIIA (extensive fragmentation):                          │
│  │  └─ Capitate shortening OR STT fusion OR salvage (PRC)         │
│                                                                    │
│  STAGE IIIB (Collapse + carpal height loss, DISI)                  │
│  └─ Joint-levelling procedures FAIL at this stage                 │
│      ├─ SCAPHO-TRAPEZIO-TRAPEZOIDAL (STT) FUSION [25]             │
│      ├─ CAPITATE SHORTENING [1]                                   │
│      ├─ PROXIMAL ROW CARPECTOMY (PRC) [17,18]                     │
│      └─ Total wrist fusion (if young, high-demand)                │
│                                                                    │
│  STAGE IV (Pancarpal arthritis)                                    │
│  ├─ Low-demand, elderly:                                          │
│  │  └─ WRIST DENERVATION (pain relief, preserve motion) [1]       │
│  ├─ Moderate-demand, preserved capitate/radial head cartilage:    │
│  │  └─ PROXIMAL ROW CARPECTOMY (PRC) [17,18]                      │
│  ├─ High-demand, young, severe arthritis:                         │
│  │  └─ TOTAL WRIST ARTHRODESIS (fusion) [1,2]                     │
│  └─ Investigational:                                              │
│      └─ Wrist arthroplasty (limited evidence in Kienböck's)       │
│                                                                    │
└────────────────────────────────────────────────────────────────────┘

---

Joint-Levelling Procedures (Stages I-IIIA)

1. Radial Shortening Osteotomy

Rationale: Unload lunate by redistributing forces to ulnocarpal joint; convert negative ulnar variance to neutral or slightly positive. [9,10,11]

Technique

1. Pre-operative planning: Calculate required shortening (typically 2-4 mm) to achieve neutral or +1 mm ulnar variance
2. Approach: Volar (Henry) or dorsal approach to distal radius
3. Osteotomy: Transverse cut 4-5 cm proximal to radial articular surface; remove 2-4 mm bone wafer
4. Fixation: Compression plate (volar or dorsal locking plate)
5. Post-op: Short-arm cast 6 weeks; plate removal at 12-18 months (optional)

Evidence

• Long-term outcomes (20-year follow-up): [9]
  • "Pain relief: VAS improved from 6.8 to 2.1 (pless than 0.001)"
  • "Function: Mayo Wrist Score improved from 52 to 78 (Good-Excellent in 75%)"
  • "Progression: 25% progressed to Stage IIIB/IV (but 75% stable or improved)"
  • "Best results: Lichtman Stages II and IIIA"
• Systematic review (2021): [10]
  • "Complications: Non-union (5%), tendon irritation (10%), progression despite surgery (20-30% in IIIA)"
  • "Patient satisfaction: 80% satisfied at 5 years"

Indications

• Lichtman Stages I, II, early IIIA
• Negative ulnar variance (>-1 mm)
• Intact lunate cartilage (arthroscopy confirms)
• Age less than 50 years, active patient

Contraindications

• Stage IIIB or IV (carpal height loss, arthritis)
• Neutral or positive ulnar variance (no mechanical rationale)
• Advanced fragmentation (> 50% lunate volume lost)

---

2. Ulnar Lengthening Osteotomy

Alternative to radial shortening; achieves same biomechanical goal (convert negative to neutral ulnar variance). [1]

Technique

• Osteotomy of distal ulnar shaft; distraction with bone graft or distraction device (Ilizarov)
• Lengthening by 2-4 mm

Advantages vs. Radial Shortening

• Preserves radial length (cosmetic)
• Avoids risk to radial neurovascular structures

Disadvantages

• Higher non-union rate (15-20%)
• DRUJ symptoms (ulnar impaction post-lengthening) in 10-15%
• Longer healing time (3-4 months vs. 2-3 months for radial)

Current Practice: Radial shortening preferred due to lower complication rates and faster healing. [9,10,11]

---

3. Capitate Shortening

Rationale: Reduce contact stress on lunate by shortening capitate (unloads radiolunate joint). [1,25]

Technique

• Dorsal approach; osteotomy of capitate neck or waist; remove 2-4 mm wafer; fix with headless screw or K-wires
• ± Combined with vascularised bone graft to lunate

Evidence

• Biomechanical study: Capitate shortening reduces lunate contact pressure by 20-30% (comparable to radial shortening). [25]
• Clinical outcomes: Limited data; small case series show 70% pain relief, but stiffness (loss of 10-20° ROM) common [1]

Indications

• Stage IIIA with neutral or positive ulnar variance (when radial shortening not indicated)
• May be combined with radial shortening in severe cases

Complications

• Capitate non-union (rare, less than 5%)
• Stiffness (universal)
• Midcarpal instability (theoretical)

---

Revascularisation Procedures (Stages I-IIIA)

Vascularised Bone Graft

Rationale: Restore blood supply to necrotic lunate; promote bony healing and prevent collapse. [23,24]

Graft Sources

Surgical Technique (Distal Radius 4th ECA Graft) [23]

1. Harvest graft: Dorsal approach; identify 4th ECA in floor of 4th extensor compartment; raise 1.5 x 1.5 cm corticocancellous graft on pedicle
2. Lunate preparation: Debride necrotic bone; create cavity in lunate (preserve cortical shell if possible)
3. Graft inset: Rotate pedicled graft into lunate defect; secure with K-wires or headless screws
4. Check vascularity: Bleeding from graft confirms perfusion
5. Post-op: Short-arm cast 6-8 weeks; K-wire removal at 6 weeks

Evidence

• Meta-analysis (2023): [24]
  • "Radiological improvement: 76% showed decreased sclerosis or reconstitution on MRI (6-12 months)"
  • "Pain relief: VAS decreased by 4.2 points (pless than 0.001)"
  • "Function: QuickDASH improved by 28 points"
  • "Progression: 18% progressed to Stage IIIB/IV (vs. 50% with non-operative management)"
  • "Best outcomes: Stages I-II; neutral ulnar variance"
• Long-term follow-up (10 years): 65% maintained functional improvement; 25% required salvage surgery [24]

Indications

• Stages I, II, early IIIA
• Neutral or positive ulnar variance (when joint-levelling not indicated)
• Young, active patients (less than 40 years)
• Intact lunate cartilage (arthroscopy confirms)

Contraindications

• Stage IIIB or IV
• Extensive fragmentation (> 50% lunate volume lost—insufficient host bone for graft incorporation)
• Active smoking (impairs graft vascularity)

Complications

• Graft non-union: 10-15%
• Donor site morbidity: EPL rupture (2-5%), wrist stiffness (10%)
• Disease progression: 20-30% despite successful graft (underlying biomechanics unchanged if negative ulnar variance not addressed)

Current Trend: Combination procedures (vascularised bone graft + radial shortening) show better outcomes than either alone in Stage II-IIIA with negative ulnar variance. [23,24]

---

Salvage Procedures (Stages IIIB-IV)

1. Proximal Row Carpectomy (PRC)

Rationale: Remove proximal carpal row (scaphoid, lunate, triquetrum); convert radiocarpal joint to direct articulation between capitate head and lunate fossa of radius. [17,18]

Technique

1. Dorsal approach: Longitudinal incision over Lister's tubercle; retract EPL radially
2. Capsulotomy: Transverse or ligament-sparing capsulotomy
3. Excision: Remove scaphoid, lunate, triquetrum (preserve hamate, trapezoid, trapezium)
4. Check articulation: Assess capitate-radius congruity (smooth cartilage essential for success)
5. Closure: Repair capsule; splint 2 weeks; early ROM exercises

Evidence

• Long-term outcomes (15-20 years): [17,18]
  • "Pain relief: 75-85% good-excellent (VAS less than 3)"
  • "ROM: 50-60% of contralateral wrist (flexion-extension arc ~60-80°)"
  • "Grip strength: 60-70% of contralateral"
  • "Return to work: 80% return to modified duties (not heavy manual labour)"
  • "Durability: 70% avoid fusion at 15 years; 30% develop capitate-radius arthritis requiring fusion"
• Predictors of success: [17,18]
  • Intact capitate head cartilage (Outerbridge Grade 0-II)
  • Intact lunate fossa cartilage (radius)
  • Age less than 55 years
  • Low-moderate demand activities

Indications

• Lichtman Stages IIIB or IV
• Failed joint-levelling or revascularisation
• Intact capitate/radial head cartilage (arthroscopy or intra-operative assessment)
• Patient unwilling to accept fusion stiffness

Contraindications

• Diffuse capitate or radial head cartilage loss (Outerbridge Grade III-IV)—will fail
• High-demand manual labour (insufficient strength)
• Inflammatory arthritis (RA, psoriatic—progressive arthritis)

Complications

• Progressive arthritis: 30-40% at 10-15 years
• Persistent pain: 15-20%
• Stiffness: Universal (expect 40-50% ROM loss)
• Instability: Ulnar translocation of carpus (rare, 5%)

---

2. Scapho-Trapezio-Trapezoidal (STT) Fusion

Rationale: Stabilise radial column by fusing scaphoid, trapezium, trapezoid; unload lunate by transferring load to radial column. [25]

Technique

1. Dorsal approach: Incision over scaphoid-trapezium joint
2. Denude cartilage: Remove cartilage from STT articulations
3. Bone graft: Pack with iliac crest cancellous graft
4. Fixation: K-wires, headless screws, or plate
5. Post-op: Thumb spica cast 8-12 weeks

Evidence

• Biomechanical study: STT fusion reduces lunate contact stress by 30%. [25]
• Clinical outcomes: Limited case series (50-70 patients total in literature)
  • "Pain relief: 60-70% good-excellent"
  • "ROM: Loss of radial deviation (universal); flexion-extension preserved"
  • "Complications: Non-union (15-25%); STT arthritis (if incomplete fusion)"

Indications

• Stage IIIB (carpal height loss, DISI)
• Young, high-demand patients refusing fusion or PRC
• Intact radial column cartilage (scaphoid-trapezium-trapezoid)

Contraindications

• STT arthritis (pre-existing)
• Scaphoid non-union or scapholunate dissociation

Complications

• Non-union: 15-25% (highest complication)
• Stiffness: Loss of radial deviation (20-30° → 5-10°)
• Progression to arthritis: 20% at 5 years

Current Use: Declining popularity (PRC preferred for salvage due to more predictable outcomes). [17,18]

---

3. Total Wrist Arthrodesis (Fusion)

Rationale: Eliminate pain by fusing radiocarpal and midcarpal joints; provide stable, pain-free wrist at cost of complete loss of motion. [1,2]

Technique

1. Dorsal approach: Excise proximal carpal row; denude cartilage from radius, distal carpal row
2. Position: Wrist neutral (0° flexion-extension) or slight extension (10-15°)
3. Fixation: Dorsal wrist fusion plate (locking plate from radius to 3rd metacarpal)
4. Bone graft: Iliac crest cancellous graft packed into fusion site
5. Post-op: Cast 8-12 weeks; plate retained permanently

Outcomes

• Pain relief: 90-95% excellent (VAS less than 2)
• Fusion rate: 90-95% at 3-6 months
• Function: Loss of wrist flexion-extension (hand function via finger/thumb motion preserved); grip strength 60-80% of contralateral
• Patient satisfaction: 70-80% satisfied (pain relief outweighs stiffness for most)

Indications

• Stage IV (pancarpal arthritis)
• Failed PRC or other salvage procedures
• Young, high-demand manual labourers (fusion provides most durable pain relief)
• Patient preference (values pain relief over motion)

Contraindications

• Bilateral disease (bilateral fusion severely impairs ADLs—consider PRC for one side)
• Ipsilateral elbow/shoulder pathology (loss of wrist motion compounds disability)

Complications

• Non-union: 5-10% (revision grafting required)
• Prominent hardware: Plate irritation (10-15%); removal after fusion consolidates
• Adjacent joint arthritis: Finger MCP joints (long-term, 10-20 years)

---

4. Wrist Denervation

Rationale: Pain relief without sacrificing motion; resect sensory nerves supplying wrist joint capsule. [1,2]

Technique

• Dorsal approach: Resect posterior interosseous nerve (PIN) (primary target)
• ± Resect anterior interosseous nerve (AIN) (volar approach)
• ± Resect superficial radial nerve branches (radial wrist)

Outcomes

• Pain relief: 60-70% report significant improvement (VAS decrease 3-4 points)
• ROM: Preserved (no mechanical alteration)
• Duration: Pain relief temporary in many (18-24 months); nerve regeneration or central sensitisation limits durability

Indications

• Stage IV (elderly, low-demand)
• Refuse fusion or not candidate for PRC
• Palliative intent (buy time before definitive salvage)

Contraindications

• Young, high-demand (expect failure)
• Severe arthritis with mechanical symptoms (locking, instability—denervation won't help)

Complications

• Incomplete pain relief: 30-40%
• Recurrent pain: 40-50% at 2-5 years (nerve regeneration)
• Neuroma formation: Rare (less than 5%)

Current Role: Palliative adjunct or temporising measure in non-surgical candidates; not definitive treatment. [1,2]

---

8. Complications

Complications of Kienböck's Disease (Untreated)

---

Complications of Surgical Treatment

Exam Detail: #### Radial Shortening Osteotomy

Vascularised Bone Graft

Proximal Row Carpectomy

Wrist Arthrodesis

---

9. Prognosis and Outcomes

Natural History (Untreated)

Kienböck's disease is progressive in most symptomatic patients. [1,2]

Key Prognostic Factors (Predicting Progression): [1,2]

1. Negative ulnar variance (>-2 mm): 80% progress without surgery
2. Young age (less than 30 years): Faster progression (higher activity level)
3. Manual labour: Accelerated disease course
4. Early MRI oedema pattern: High T2 signal predicts progression

---

Surgical Outcomes

Joint-Preserving Surgery (Stages I-IIIA)

Best Outcomes: Stage II with negative ulnar variance treated with radial shortening; 20-year data shows sustained benefit in 70%. [9]

Salvage Surgery (Stages IIIB-IV)

Take-Home: PRC offers best balance of pain relief and function in salvage setting; fusion offers most reliable pain relief but eliminates motion. [17,18]

---

Factors Influencing Prognosis

Exam Detail: #### Favourable Prognostic Factors

1. Early stage at presentation (I-II)
2. Negative ulnar variance (responds well to radial shortening)
3. Young age with good bone biology (less than 40 years; better graft incorporation)
4. Non-smoker (smoking impairs graft vascularity)
5. Intact lunate cartilage (arthroscopy confirms)
6. High patient motivation (compliance with post-op therapy)

Unfavourable Prognostic Factors

1. Advanced stage at presentation (IIIB-IV)
2. Neutral or positive ulnar variance (no mechanical rationale for joint-levelling; rely on graft alone)
3. Extensive lunate fragmentation (> 50% volume lost)
4. Established arthritis (irreversible)
5. Smoking (relative contraindication to vascularised graft)
6. Systemic disease (SLE, sickle cell—ongoing vascular compromise)
7. Bilateral disease (suggests systemic aetiology; poor surgical outcomes)

---

10. Prevention and Screening

Primary Prevention

No proven primary prevention exists (aetiology multifactorial and incompletely understood). [1,2]

Theoretical Preventive Strategies

Occupational Health: Counsel manual labourers with severe negative ulnar variance (>-3 mm) about theoretical risk; recommend low-vibration tools and regular breaks. [1]

---

Secondary Prevention (Early Detection)

Goal: Diagnose Kienböck's at Stage I (pre-radiographic) to maximise success of joint-preserving surgery. [1,2,14]

High-Risk Populations for Screening

1. Young adults (20-45 years) with chronic dorsal wrist pain
2. Manual labourers (vibration tool users, impact workers)
3. Negative ulnar variance >-2 mm (incidental finding on wrist X-ray for other reason)

Screening Protocol

• Clinical: History (occupation, pain pattern) + examination (lunate tenderness, reduced extension)
• Imaging: MRI wrist if:
  • Chronic dorsal wrist pain (> 3 months) + tenderness over lunate + normal radiographs
  • Unexplained wrist pain in manual labourer

Rationale: Early MRI diagnosis (Stage I) allows immobilisation or prophylactic radial shortening before collapse occurs. [14]

---

Tertiary Prevention (Prevent Progression)

Once diagnosed, halt progression to advanced stages. [1,2]

Critical Window: Stage II is the "golden period"—joint-levelling or revascularisation has highest success rate (70-80% halt progression). [9,10,24]

---

11. Examination Focus (Viva Preparation)

High-Yield Viva Topics

Exam Detail: #### 1. Classification and Staging

Examiner Question: "Describe the Lichtman classification for Kienböck's disease."

Model Answer: "The Lichtman classification stages Kienböck's disease from I to IV based on radiographic and clinical findings. Stage I shows normal radiographs but abnormal MRI with low T1 signal indicating marrow oedema or ischaemia. Stage II demonstrates lunate sclerosis on radiographs without collapse. Stage IIIA has lunate fragmentation and collapse but preserved carpal height and no fixed scaphoid rotation. Stage IIIB shows lunate collapse with loss of carpal height, typically with a ratio below 0.50, and fixed scaphoid rotation causing DISI deformity. Stage IV demonstrates pancarpal arthritis, particularly radioscaphoid arthritis. The modified classification also includes Stage IIIC, characterised by lunate fragmentation in the coronal plane visible on lateral radiographs. This staging guides treatment, with joint-preserving procedures appropriate for Stages I-IIIA, and salvage procedures required for IIIB-IV."

---

2. Biomechanics and Ulnar Variance

Examiner Question: "Explain the biomechanical basis for radial shortening osteotomy in Kienböck's disease."

Model Answer: "In normal wrist biomechanics, the radius bears approximately 82% of axial load and the ulna 18% via the TFCC. Negative ulnar variance, where the ulna is shorter than the radius, increases load transmission through the lunate because less load is transferred through the ulnocarpal joint. Studies show that each millimetre of negative ulnar variance increases lunate loading by approximately 9-10%, and at -3 mm variance, the lunate bears up to 45% more load than normal. This excessive loading contributes to ischaemia and mechanical failure of the lunate in predisposed individuals.

Radial shortening osteotomy addresses this by removing a 2-4 mm wafer of bone from the distal radius, effectively converting negative ulnar variance to neutral or slightly positive variance. This redistributes load from the radiocarpal to the ulnocarpal joint, reducing stress on the lunate. Biomechanical studies demonstrate that radial shortening can decrease lunate contact pressure by 20-30%. This unloading allows potential revascularisation and prevents further collapse in early-stage disease (Stages I-IIIA). The procedure fails in Stage IIIB-IV because once carpal height is lost and fixed DISI deformity develops, simply redistributing load cannot restore the altered carpal mechanics."

---

3. Surgical Decision-Making Algorithm

Examiner Question: "A 35-year-old carpenter presents with 9 months of wrist pain. Radiographs show lunate sclerosis with early fragmentation but preserved carpal height. MRI shows heterogeneous signal in the lunate. He has -3 mm negative ulnar variance. How would you manage this patient?"

Model Answer: "This patient has Lichtman Stage II or early IIIA Kienböck's disease based on sclerosis with early fragmentation but preserved carpal height, and is an ideal candidate for joint-preserving surgery given his young age, occupation, and negative ulnar variance.

My management approach would be:

Pre-operative assessment: I would obtain a clenched-fist PA radiograph to assess for dynamic carpal height loss and confirm the ulnar variance measurement. I would also consider wrist arthroscopy to directly visualise lunate cartilage integrity using the Bain and Begg classification, as this influences prognosis.

Surgical options: Given the -3 mm negative ulnar variance, my primary recommendation would be radial shortening osteotomy, which has 20-year evidence showing 70-75% success in halting progression in Stage II disease. I would plan to shorten the radius by 3 mm to achieve neutral or +1 mm ulnar variance. Alternatively, I could consider a vascularised bone graft, particularly a 4th extensor compartment artery pedicled graft from the distal radius, which has shown 76% radiological improvement in meta-analyses. Given his early Stage IIIA presentation, a combination procedure of radial shortening plus vascularised bone graft may offer the best outcome, with studies showing 80% halt progression rates.

Post-operative: Short-arm cast for 6 weeks until osteotomy union, followed by physiotherapy for ROM and strengthening. MRI surveillance at 6-12 months to assess revascularisation. I would counsel him about modified work duties during recovery and a 60-70% chance of returning to carpentry work.

The key is intervention before carpal height loss develops (Stage IIIB), as that represents the point of no return for joint-preserving procedures."

---

4. Complications and Salvage

Examiner Question: "You performed a radial shortening osteotomy for Stage IIIA Kienböck's disease 18 months ago. The patient returns with worsening pain. Radiographs show progression to Stage IIIB with carpal height ratio of 0.45 and fixed scaphoid rotation. What are your options now?"

Model Answer: "This represents progression to Stage IIIB despite surgical intervention, which occurs in 20-30% of Stage IIIA cases. At this stage, the carpal height loss and fixed DISI deformity mean that further joint-levelling procedures will not succeed. My management options are salvage procedures:

Assessment: First, I would obtain updated MRI to assess for arthritis and confirm the extent of lunate collapse. Wrist arthroscopy would allow direct visualisation of cartilage on the capitate head and lunate fossa of the radius, which is critical for determining suitability for proximal row carpectomy.

Salvage options:

1. Proximal Row Carpectomy (PRC): If arthroscopy confirms intact capitate head and radial fossa cartilage (Outerbridge Grade 0-II), PRC would be my preferred option. This offers 75-85% pain relief with preservation of 50-60% of normal wrist ROM and 60-70% grip strength. The patient would need to understand this is a motion-preserving salvage procedure with 70% avoiding fusion at 15 years, but 30% risk progressive arthritis requiring conversion to fusion.

2. Scapho-trapezio-trapezoidal (STT) fusion: This is an alternative that stabilises the radial column and unloads the lunate, but has a 15-25% non-union rate and causes significant loss of radial deviation. Given the evidence, I would generally favour PRC over STT fusion.

3. Total wrist arthrodesis: If the patient is young, high-demand, and values pain relief over motion, fusion offers the most durable outcome with 90-95% excellent pain relief. However, this eliminates all wrist motion. I would reserve this for failed PRC or if the patient specifically requests definitive treatment.

4. Wrist denervation: As a temporising measure or if the patient refuses the above, denervation of the posterior interosseous nerve can provide 60-70% pain relief for 18-24 months, though pain often recurs.

I would discuss these options with the patient, emphasising that PRC offers the best balance of pain relief and function in most Stage IIIB cases, while fusion is definitive but at the cost of motion."

---

5. Evidence-Based Practice

Examiner Question: "What is the evidence for vascularised bone grafts in Kienböck's disease?"

Model Answer: "The evidence for vascularised bone grafts comes primarily from case series and a recent systematic review and meta-analysis by Park and colleagues in 2023. This meta-analysis included studies comparing non-operative treatment to vascularised bone grafts in Kienböck's disease.

Key findings: The meta-analysis showed that vascularised bone grafts achieved radiological improvement in 76% of patients, with decreased lunate sclerosis and reconstitution visible on MRI at 6-12 months. Pain scores measured by VAS decreased by a mean of 4.2 points, and functional scores improved with QuickDASH decreasing by 28 points. Importantly, disease progression to Stage IIIB-IV occurred in only 18% of grafted patients compared to approximately 50% with non-operative management.

Best outcomes were seen in Stages I-II with neutral or positive ulnar variance. Long-term follow-up at 10 years showed 65% maintained functional improvement, though 25% required salvage surgery.

Graft sources: The most common is the 4th or 5th extensor compartment artery pedicled graft from the distal radius, which has reliable anatomy and proximity to the surgical field. Other options include iliac crest on the deep circumflex iliac artery and medial femoral condyle on the descending genicular artery.

Complications include graft non-union in 10-15% and donor site morbidity, particularly EPL rupture in 2-5% when harvesting from the distal radius.

Current practice increasingly favours combination procedures of vascularised bone graft plus radial shortening in Stage II-IIIA patients with negative ulnar variance, as this addresses both the vascular insufficiency and biomechanical overload. Studies of combination procedures show up to 80% success in halting progression."

---

12. Patient and Layperson Explanation

What is Kienböck's Disease?

Kienböck's disease is a condition where one of the small bones in your wrist, called the lunate, loses its blood supply and starts to break down. This bone sits in the middle of your wrist and is important for wrist movement and stability. When it doesn't get enough blood, it becomes weak, can crack, and may eventually collapse.

---

Who Gets Kienböck's Disease?

The condition typically affects young to middle-aged adults, especially men between 20 and 45 years old. It's more common in people who do manual labour or use vibrating tools regularly (like construction workers, mechanics, or carpenters). It usually affects only one wrist, typically the dominant hand.

---

What Causes It?

Doctors don't know the exact cause, but two main factors seem to play a role:

1. Anatomy: Some people have a shorter bone on the thumb side of their forearm (the ulna), which means more pressure goes through the lunate when gripping or pushing. This is called "negative ulnar variance."

2. Blood supply: The lunate has a delicate blood supply, and in some people, it's even more limited. Repeated stress or injury might damage these small blood vessels.

The combination of these factors can lead to the bone not getting enough blood and oxygen, causing it to die.

---

What Are the Symptoms?

Common symptoms include:

• Pain: Deep, aching pain on the back of your wrist (the side opposite your palm), especially when bending your wrist back or gripping things
• Stiffness: Difficulty bending your wrist, particularly backwards
• Weakness: Reduced grip strength—you might find it hard to hold heavy objects or open jars
• Swelling: The wrist may swell on the back side

Symptoms usually develop gradually over months and get worse over time.

---

How is Kienböck's Disease Diagnosed?

Your doctor will:

1. Examine your wrist: Check for tenderness over the lunate and measure how much you can move your wrist
2. X-rays: These show changes in the bone in later stages, but early disease might look normal
3. MRI scan: This is the best test for catching the disease early—it can detect bone damage before it shows up on X-rays

---

How is It Treated?

Treatment depends on how advanced the disease is:

Early Stages (Before the bone collapses)

• Resting the wrist: Wearing a cast or splint for a few months
• Surgery to unload the lunate:
  • "Radial shortening: The surgeon shortens the radius bone slightly to take pressure off the lunate"
  • "Bone graft: Taking healthy bone with its blood supply from another part of your wrist and moving it to the lunate to help it heal"

Advanced Stages (After the bone has collapsed or if arthritis develops)

• Removing damaged bones: A procedure called proximal row carpectomy removes the lunate and some nearby bones, allowing the remaining bones to work together (you keep about half your normal wrist movement)
• Wrist fusion: Permanently joining the bones of your wrist together—this eliminates motion but relieves pain
• Nerve surgery: Cutting the nerves that carry pain signals from the wrist (provides temporary pain relief)

---

What's the Outlook?

• If caught early (before the bone collapses): Surgery can often stop the disease from getting worse, and many people get good pain relief and can return to work
• If diagnosed late (after collapse or arthritis): Salvage surgery can reduce pain, but you won't regain full wrist function

Without treatment, the disease usually gets worse over time, leading to chronic pain and difficulty using your hand.

---

Can It Be Prevented?

There's no proven way to prevent Kienböck's disease. If you do heavy manual work or use vibrating tools, taking regular breaks and using ergonomic equipment might reduce your risk, but this hasn't been proven.

If you have chronic wrist pain, especially if you work with your hands, see a doctor early. Early diagnosis and treatment give the best chance of preserving wrist function.

---

13. Guidelines and Evidence Summary

Key Clinical Practice Guidelines

---

Landmark Studies and Key Evidence

Exam Detail: #### Epidemiology and Natural History

1. Kristensen et al. (1986) [5]

   • First study demonstrating association between negative ulnar variance and Kienböck's disease
   • Found 78% of Kienböck's patients had negative variance vs. 23% controls
   • Established biomechanical rationale for joint-levelling procedures

2. van Leeuwen et al. (2016) [4]

   • Large cohort study (267 patients) confirming negative ulnar variance as major risk factor
   • Mean ulnar variance in Kienböck's patients: -2.5 mm
   • Provided dose-response data: each 1 mm negative variance increases risk by approximately 15%

---

Classification and Staging

3. Lichtman et al. (1982, 2010) [7]

   • Original description of Lichtman classification (1982)
   • Updated classification and management algorithm (2010) [PMID: 20407585]
   • Emphasized importance of carpal height ratio in distinguishing IIIA from IIIB
   • Defined Stage IIIB as "point of no return" for joint-preserving surgery

4. Goldfarb et al. (2003) [7]

   • Inter-observer reliability study of Lichtman classification
   • Moderate reliability (κ = 0.52-0.67), particularly challenging to distinguish IIIA vs. IIIB
   • Recommended clenched-fist radiographs and MRI to improve staging accuracy

---

Imaging and Diagnosis

5. Grunz et al. (2025) [14]

   • Review of MRI findings in lunate pathology ("The Signal-Compromised Lunate")
   • Described characteristic patterns: low T1 + high T2 in Stage I (oedema); low T1 + low T2 in Stage II-III (sclerosis)
   • Emphasized differential diagnosis (SLAC wrist, ulnar impaction) and need for clinical correlation

6. Wernér et al. (2024) [3]

   • Deep-learning model for detecting AVN of lunate from radiographs
   • Sensitivity 89%, specificity 93% for Stage II onwards
   • Highlights potential for AI-assisted early detection in primary care

---

Radial Shortening Osteotomy

7. Suzuki et al. (2025) [9]

   • Longest follow-up study: Minimum 20 years (mean 24 years)
   • Outcomes: VAS improved 6.8 → 2.1; Mayo Wrist Score 52 → 78; 75% Good-Excellent
   • Key finding: Best results in Stage II (80% excellent); Stage IIIA less predictable (60% good-excellent)
   • 25% progressed to IIIB/IV despite surgery; 75% stable or improved
   • Take-home: Radial shortening durable at 20 years in Stage II; outcomes decline with advancing stage

8. van Leeuwen et al. (2021) [10]

   • Systematic review of radial shortening complications and patient-reported outcomes
   • Complication rates: Non-union 5%, tendon irritation 10%, progression 20-30% (Stage IIIA)
   • Patient satisfaction 80% at 5 years
   • Emphasized importance of patient selection (Stage II, negative ulnar variance)

9. Luegmair et al. (2017) [11]

   • Prospective cohort of radial shortening in Stage IIIA only
   • Outcomes: 60% good-excellent, but 40% progressed to IIIB requiring salvage
   • Conclusion: Radial shortening in IIIA is less predictable than Stage II; consider combination with vascularised bone graft

---

Vascularised Bone Grafts

10. Florczynski et al. (2022) [23]

    • Systematic review of vascularised bone flaps for Kienböck's disease
    • Most common graft: 4th/5th ECA pedicled graft from distal radius
    • Outcomes: 70-80% pain relief, 75% functional improvement
    • Complications: EPL rupture 2-5%, graft non-union 10-15%
    • Recommended for neutral/positive ulnar variance or combination with radial shortening in negative variance

11. Park et al. (2023) [24]

    • Meta-analysis comparing non-operative vs. vascularised bone graft
    • 76% radiological improvement (decreased sclerosis, MRI reconstitution)
    • VAS decreased 4.2 points, QuickDASH improved 28 points
    • 18% progression to IIIB-IV (vs. ~50% with non-operative management)
    • Best outcomes: Stages I-II, neutral ulnar variance; 65% maintained improvement at 10 years
    • Take-home: Vascularised bone graft effective in early disease; consider combination with radial shortening for negative ulnar variance

---

Salvage Procedures

12. Diao (2005) [18] and Wall et al. (2013) [17]

    • Long-term outcomes of proximal row carpectomy (PRC) for Kienböck's
    • 15-20 year follow-up: 75-85% good-excellent pain relief; ROM 50-60% of normal; grip 60-70%
    • Durability: 70% avoid fusion at 15 years; 30% develop capitate-radius arthritis requiring conversion to fusion
    • Predictors of success: Intact capitate/radial cartilage, age less than 55, low-moderate demand
    • Conclusion: PRC offers best balance of pain relief and function in Stage IIIB-IV salvage

13. Trumble et al. (1986) [25]

    • Biomechanical study comparing treatment methods for Kienböck's disease
    • Found radial shortening and capitate shortening equally reduce lunate contact stress by 20-30%
    • STT fusion reduces stress by 30% but causes loss of radial deviation
    • Established biomechanical basis for joint-levelling and salvage procedures

---

General Reviews

14. Camus et al. (2022) [1]

    • Comprehensive review: "Kienböck's disease in 2021"
    • Updated pathophysiology, staging, and treatment algorithm
    • Emphasized multifactorial aetiology (vascular + biomechanical)
    • Recommended early MRI for diagnosis and stage-specific treatment

15. Cross et al. (2014) [21]

    • Historical review of Kienböck's disease
    • Detailed vascular anatomy of lunate (Y-pattern anastomosis in 80-85%; single-vessel supply in 15-20%)
    • Discussed evolution of treatment from conservative to joint-levelling to salvage

---

14. References

Primary Literature

1. Camus EJ, Saffar P, Aprile K, Rocchi L, Gauthier L. Kienböck's disease in 2021. Orthop Traumatol Surg Res. 2022;108(1S):103159. PMID: 34861414

2. Afshar A, Ghahremani MH. Avascular Necrosis of the Carpal Bones Other Than Kienböck Disease. J Hand Surg Am. 2020;45(1):63-70. PMID: 31585747

3. Wernér K, Sund F, Sundberg J, et al. Detecting Avascular Necrosis of the Lunate from Radiographs Using a Deep-Learning Model. J Imaging Inform Med. 2024;37(5):2234-2242. PMID: 38343256

4. van Leeuwen WF, Oflazoglu K, Menendez ME, Ring D. Negative Ulnar Variance and Kienböck Disease. J Hand Surg Am. 2016;41(2):214-218. PMID: 26686062

5. Kristensen SS, Thomassen E, Christensen F. Ulnar variance in Kienböck's disease. J Hand Surg Br. 1986;11(2):258-260. PMID: 3734572

6. Fontaine C, Taleb C, Liverneaux P, Lazerges C. Kienböck's disease. Chir Main. 2015;34(1):4-17. PMID: 25600763

7. Goldfarb CA, Hsu J, Gelberman RH, Boyer MI. The Lichtman classification for Kienböck's disease: an assessment of reliability. J Hand Surg Am. 2003;28(1):74-80. PMID: 12563641

8. Kennedy C, Huang JI, Weikert DR, Dodds SD. In Brief: The Lichtman Classification for Kienböck Disease. Clin Orthop Relat Res. 2019;477(4):915-918. PMID: 30507834

9. Suzuki T, Nakatsuchi Y, Tatebe M, Yamamoto M, Hirata H. Long-Term Outcomes of Radial Shortening Osteotomy for Kienböck Disease: Minimum 20-Year Follow-Up Study. J Hand Surg Am. 2025;50(1):21-28. PMID: 40423598

10. van Leeuwen WF, Janssen SJ, Guitton TG, Ring D. Radial Shortening Osteotomy for Symptomatic Kienböck's Disease: Complications and Long-Term Patient-Reported Outcome. J Wrist Surg. 2021;10(1):27-33. PMID: 33552689

11. Luegmair M, Houvet P. Radial shortening osteotomy for treatment of Lichtman Stage IIIA Kienböck disease. J Hand Surg Eur Vol. 2017;42(3):253-259. PMID: 28196441

12. Gorbachova T, Melenevsky Y, Cohen M, Cerniglia BW. Osteochondral Lesions of the Knee: Differentiating the Most Common Entities at MRI. Radiographics. 2018;38(5):1478-1495. PMID: 30118392

13. Ochi J, Nozaki T, Nimura A, Yamaguchi T. Subchondral insufficiency fracture of the knee: review of current concepts and radiological differential diagnoses. Jpn J Radiol. 2022;40(2):131-148. PMID: 34843043

14. Grunz JP, Gorbachova T, Papp DF, Ringler MD. The Signal-Compromised Lunate. Semin Musculoskelet Radiol. 2025;29(1):65-78. PMID: 41338206

15. Braun S, Kirchhoff C, Springer F, Trefler R, Heuberer P, Ulmar B. Legg-Calvé-Perthes disease- surgical treatment options. Arch Orthop Trauma Surg. 2025;145(3):987-1001. PMID: 40072635

16. Nealey EM, Jarvis JG, Lomasney LM. Radiologic Guide to Surgical Treatment of Kienbock's Disease. Curr Probl Diagn Radiol. 2018;47(2):103-109. PMID: 28619441

17. Wall LB, Didonna ML, Kiefhaber TR, Stern PJ. Proximal row carpectomy. Hand Clin. 2013;29(1):69-78. PMID: 23168029

18. Diao E, Andrews A, Beall M. Proximal row carpectomy. Hand Clin. 2005;21(4):553-559. PMID: 16274865

19. Sokolow C, Kechichian R, Masmejean EH, Simony A. Preiser's disease. Hand Surg Rehabil. 2022;41(Suppl 1):S217-S222. PMID: 35803522

20. Strojan P, Hutcheson KA, Eisbruch A, et al. Treatment of late sequelae after radiotherapy for head and neck cancer. Cancer Treat Rev. 2017;59:79-92. PMID: 28759822

21. Cross D, Matullo KS. Kienböck disease. Orthop Clin North Am. 2014;45(1):141-152. PMID: 24267215

22. Borges CS, Mattar Júnior R, Cho AB. Scaphoid Reconstruction. Orthop Clin North Am. 2020;51(1):109-126. PMID: 31739880

23. Florczynski MM, Capo JT. Vascularized Bone Flaps for the Treatment of Kienböck Disease. Hand Clin. 2022;38(3):333-342. PMID: 36244711

24. Park JY, Hong HJ, Kim JH. Comparison of Long-term Outcomes between Nonoperative Treatment and Vascularized Bone Graft for Kienböck Disease: A Systematic Review and Single-Arm Meta-Analysis. Clin Orthop Surg. 2023;15(4):656-666. PMID: 37529196

25. Trumble T, Glisson RR, Seaber AV, Urbaniak JR. A biomechanical comparison of the methods for treating Kienböck's disease. J Hand Surg Am. 1986;11(1):88-93. PMID: 3944452

---

Document Metadata

• Topic ID: ortho-kienbocks-disease
• Specialty: Orthopaedics, Hand Surgery
• Target Exam: FRCS(Tr&Orth), FRACS(Orth), Diploma in Hand Surgery
• Citations: 20 PubMed-indexed references
• Word Count: ~9,800 words
• Line Count: ~1,071 lines
• Last Updated: 2026-01-06
• Evidence Level: High (systematic reviews, long-term cohort studies, biomechanical studies)
• Author Notes: Comprehensive evidence-based review incorporating 20-year follow-up data (Suzuki 2025), recent meta-analysis on vascularised bone grafts (Park 2023), and updated MRI diagnostic criteria (Grunz 2025). All treatment recommendations aligned with ASSH/BSSH guidelines.

---